Effects of percutaneous varicocele repair on testicular volume: results from a 12-month follow-up.


Journal

Asian journal of andrology
ISSN: 1745-7262
Titre abrégé: Asian J Androl
Pays: China
ID NLM: 100942132

Informations de publication

Date de publication:
Historique:
pubmed: 4 1 2019
medline: 19 5 2020
entrez: 4 1 2019
Statut: ppublish

Résumé

Varicocele is a common finding in men. Varicocele correction has been advocated for young patients with testicular hypotrophy, but there is a lack of morphofunctional follow-up data. We assessed whether percutaneous treatment of left varicocele is associated with testicular "catch-up growth" in the following 12 months by retrospectively reviewing data from an electronic database of 10 656 patients followed up in our clinic between 2006 and 2016. We selected all young adults (<35 years) with left varicocele who underwent percutaneous treatment, had a minimum of 12 months' ultrasound imaging follow-up, and had no other conditions affecting testicular volume. One hundred and fourteen men (mean±standard deviation [s.d.] of age: 22.8 ± 5.4 years) met the inclusion and exclusion criteria. Left testicular hypotrophy (LTH), defined as a ≥20% difference between left and right testicular volume at baseline, was observed in 26 (22.8%) men. Participants with LTH (mean±s.d.: 14.5 ± 2.7 ml) had lower baseline testicular volume compared to those without LTH (mean±s.d.: 15.7 ± 3.8 ml; P = 0.032). Repeated measures mixed models showed a significant interaction between LTH and time posttreatment when correcting for baseline left testicular volume (β = 0.114, 95% confidence interval [CI]: 0.018-0.210, P = 0.020), resulting in a catch-up growth of up to 1.37 ml per year (95% CI: 0.221-2.516). Age at intervention was also associated with reduced testicular volume (-0.072 ml per year, 95% CI: -0.135--0.009; P = 0.024). Percutaneous treatment of left varicocele in young adults with LTH can result in catch-up growth over 1 year of follow-up. The reproductive and psychological implications of these findings need to be confirmed in longer and larger prospective studies.

Identifiants

pubmed: 30604693
pii: 248807
doi: 10.4103/aja.aja_102_18
pmc: PMC6628742
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

408-412

Références

Urology. 2012 Jun;79(6):1340-5
pubmed: 22516359
Curr Urol Rep. 2017 May;18(5):38
pubmed: 28315171
Reprod Toxicol. 2016 Dec;66:61-67
pubmed: 27686954
Fertil Steril. 2017 Sep;108(3):378-384
pubmed: 28865535
J Endocrinol Invest. 2018 Feb;41(2):185-192
pubmed: 28647897
Urology. 2008 Mar;71(3):485-9
pubmed: 18342193
Biochem J. 2002 Aug 1;365(Pt 3):849-56
pubmed: 11982482
Pediatr Surg Int. 2015 Jul;31(7):617-25
pubmed: 25895069
Asian J Androl. 2016 Mar-Apr;18(2):262-8
pubmed: 26680032
Actas Urol Esp. 2015 Jul-Aug;39(6):392-5
pubmed: 25682355
Fertil Steril. 2014 Aug;102(2):381-387.e6
pubmed: 24907913
Andrology. 2013 Jan;1(1):109-15
pubmed: 23258638
Fertil Steril. 2017 Sep;108(3):370-377
pubmed: 28803635
Arch Gynecol Obstet. 2016 Jan;293(1):189-196
pubmed: 26223186
Transl Androl Urol. 2014 Dec;3(4):402-12
pubmed: 26816797
Fertil Steril. 2017 Sep;108(3):364-369
pubmed: 28865534
Asian J Androl. 2016 Mar-Apr;18(2):186-93
pubmed: 26732105
Eur Radiol. 2002 Jan;12(1):19-34
pubmed: 11868071
J Urol. 2013 Jan;189(1 Suppl):S146-50
pubmed: 23234621
Andrology. 2016 Sep;4(5):808-15
pubmed: 27153514
J Urol. 2015 Nov;194(5):1194-201
pubmed: 26119668
J Assist Reprod Genet. 2014 May;31(5):521-6
pubmed: 24643631
Asian J Androl. 2011 Sep;13(5):690-7
pubmed: 21685925

Auteurs

Andrea Sansone (A)

Department of Experimental Medicine, Sapienza University of Rome, Rome 00161, Italy.

Danilo Alunni Fegatelli (DA)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome 00161, Italy.

Carlotta Pozza (C)

Department of Experimental Medicine, Sapienza University of Rome, Rome 00161, Italy.

Giorgio Fattorini (G)

Department of Experimental Medicine, Sapienza University of Rome, Rome 00161, Italy.

Rosa Lauretta (R)

Unit of Endocrinology, Regina Elena National Cancer Institute, Rome 00144, Italy.

Marianna Minnetti (M)

Department of Experimental Medicine, Sapienza University of Rome, Rome 00161, Italy.

Francesco Romanelli (F)

Department of Experimental Medicine, Sapienza University of Rome, Rome 00161, Italy.

Pierleone Lucatelli (P)

Vascular and Interventional Radiology Unit, Department of Radiological, Oncological and Anatomo-Pathological Sciences, Sapienza - University of Rome, Rome 00161, Italy.

Mario Corona (M)

Vascular and Interventional Radiology Unit, Department of Radiological, Oncological and Anatomo-Pathological Sciences, Sapienza - University of Rome, Rome 00161, Italy.

Mario Bezzi (M)

Vascular and Interventional Radiology Unit, Department of Radiological, Oncological and Anatomo-Pathological Sciences, Sapienza - University of Rome, Rome 00161, Italy.

Francesco Lombardo (F)

Department of Experimental Medicine, Sapienza University of Rome, Rome 00161, Italy.

Andrea Lenzi (A)

Department of Experimental Medicine, Sapienza University of Rome, Rome 00161, Italy.

Daniele Gianfrilli (D)

Department of Experimental Medicine, Sapienza University of Rome, Rome 00161, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH